"Bezafibrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.
| Descriptor ID |
D001629
|
| MeSH Number(s) |
D02.065.277.067 D02.241.081.114.968.500.249 D02.241.223.100.100.120 D02.241.223.100.200.249 D02.355.726.305.249 D02.455.426.559.389.127.085.101 D02.455.426.559.389.127.250.249 D02.455.426.559.389.657.654.305.249
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bezafibrate".
Below are MeSH descriptors whose meaning is more specific than "Bezafibrate".
This graph shows the total number of publications written about "Bezafibrate" by people in this website by year, and whether "Bezafibrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bezafibrate" by people in Profiles.
-
Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: a putative role for Randle's cycle in its pathogenesis? Clin Endocrinol (Oxf). 1997 Mar; 46(3):365-8.
-
Non-invasive ultrasonic biopsy in the classification of early arterial lesions and in the evaluation of the rate of progression of arteriosclerosis. Panminerva Med. 1992 Jul-Sep; 34(3):107-14.